A recent study from our group illustrated that the ablation of the surface expression of the CD38 in CD4 T cells exhibited intrinsically higher levels of NAD+, which contributed to the rewiring of metabolic commitment and altered mitochondrial dynamics that renders T cells more effective in terms of anti-tumor immunity [13]. This evidence concerns the gene CD38 and neoplasm.